Big Pharma In Canada Offers C$1B In Last Attempt To Stop Drug Pricing Crackdown
November 16, 2020 at 02:25 AM EST
They say the uncertainty and complex cost-benefit analysis the new rules will bring about will discourage them from developing new drugs in the country.
